Pilot Study: Preoperative Nicotine Lozenges
NCT00586482 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 46
Last updated 2014-12-22
Summary
The goal of this pilot study is to determine the feasibility and potential effect size of nicotine lozenges as an adjunct to maintain brief preoperative abstinence, defined as not smoking the day of surgery.
Conditions
- Smoking
Interventions
- DRUG
-
Nicotine Lozenge
Nicotine lozenges, 2 or 4 mg, taken without restriction by mouth from 7 pm the evening before surgery until surgical admission the next day and a 2 minute behavioral intervention. Dosed according to time to first morning cigarette; if within 30 minutes of awakening, 4 mg lozenge used. If first cigarette smoked greater than 30 minutes of awakening, 2 mg lozenge used.
- DRUG
-
Placebo Lozenge
Placebo lozenges, matching in appearance the 2 and 4 mg active nicotine lozenges, taken by mouth without restriction from 7 pm the night before surgery to the time of surgical admission the next day and a 2 minute behavioral intervention.
- BEHAVIORAL
-
Abstinence Advisement
A brief (approximately 2 minute) behavioral intervention advising abstinence from smoking after 7 pm the night before surgery, the potential benefits of abstinence and to use a lozenge at usual smoking times.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
David O Warner, MD · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-08-31
- Primary Completion
- 2013-01-31
- Completion
- 2013-01-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy and Safety Study of Nicotine Mint Lozenge (2mg and 4mg) in Smoking Cessation
NCT00985985 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in Smokers
NCT01262170 ·Status: COMPLETED ·Phase: PHASE1
-
Innovative Interventions for Smoking Cessation
NCT01050569 ·Status: COMPLETED ·Phase: PHASE2
-
S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence
NCT00722124 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Palatability of Experimental Cigarettes - Study 2
NCT01568905 ·Status: COMPLETED ·Phase: NA
-
Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement Products
NCT01234896 ·Status: COMPLETED ·Phase: NA
-
Nalmefene Smoking Cessation Study
NCT00202696 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery
NCT00889720 ·Status: COMPLETED ·Phase: PHASE4
-
Combination Nicotine Patch / Lorcaserin for Smoking Cessation
NCT02906644 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
NCT00710034 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation
NCT07099638 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Smoking Cessation Program in the Preadmission Clinic
NCT00937508 ·Status: UNKNOWN ·Phase: PHASE4
-
Progesterone Augmentation of Nicotine Replacement Therapy Study
NCT02685072 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving
NCT01466361 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Tolerability Of Two Nicotine Dosage Forms
NCT00682461 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Using Reduced Nicotine Cigarettes in Men and Women Smokers to Combat Nicotine Addiction
NCT00264342 ·Status: COMPLETED
-
Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients
NCT04608201 ·Status: COMPLETED ·Phase: PHASE3
-
Cigarette Smoking Among Young Adults
NCT04340947 ·Status: COMPLETED ·Phase: NA
-
Provoked Craving Relief Study by NRT
NCT01476202 ·Status: COMPLETED ·Phase: PHASE2
-
Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
NCT01522963 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Nicotine Sublingual Tablets Versus Nicorette Lozenge in Healthy Smokers
NCT02906995 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study of a New Nicotine Replacement Therapy
NCT00764439 ·Status: COMPLETED ·Phase: PHASE2
-
Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol
NCT03580525 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Smoking Cessation in Menthol Flavored Cigarette Smokers
NCT02342327 ·Status: COMPLETED ·Phase: NA
-
Use of Nicotine Pouches Among Daily Smokers
NCT06043362 ·Status: RECRUITING ·Phase: NA